Oral GLP-1 pill delivers nearly 12 percent weight loss in 36 weeks, study finds

(NewsNation) — Patients taking the oral GLP-1 drug aleniglipron saw up to a 12 percent reduction in body weight after 36 weeks, according to researchers.

The study, conducted at Northwestern University, found the drug stimulates insulin secretion, suppresses appetite and increases satiety to promote weight loss.

“The difference with aleniglipron is it’s a small molecule, meaning it’s chemically made and can be taken with or without food,” said Dr. Robert Kushner, a co-author of the study and a professor at Northwestern. “Most medications we take — whether aspirin or blood pressure drugs — are small molecules. Because of that, they can potentially be combined with other medications.”

Researchers........

© The Hill